Avience Biomedicals IPO Subscription Status
Final figures at close of bidding: 15 Jul 2026, 12:00 am IST
| Category | Subscription |
|---|---|
| QIB | 196.77x |
| NII | 597.23x |
| Retail (RII) | 401.21x |
| Total | 385.24x |
Bidding day 5
Day-wise subscription
| Day | QIB | NII | Retail | Total |
|---|---|---|---|---|
| Day 4 | 0.03x | 66.3x | 58.63x | 43.61x |
| Day 5 | 196.77x | 597.23x | 401.21x | 385.24x |
Times subscribed per category (bids vs shares offered, anchor portion excluded). Bidding has closed — these are the final figures.
How the book filled
Day-by-day demand
The Avience Biomedicals book was built over 2 days: overall subscription stood at 43.61× at the close of day 4, and finished at 385.24× on day 5. On the final day it was non-institutional investors (NII) driving the book, at 597.23× of the shares set aside for the category. More than half of the final demand arrived after day 4 — a late-building book.
Category detail
Qualified institutional buyers took their portion to 196.77×. Non-institutional investors came in at 597.23×. Retail investors put in bids for 401.21× the shares reserved for them. That puts non-institutional investors (NII) at the top of the book at 597.23× and qualified institutional buyers (QIB) at the bottom at 196.77×.
What the multiple means for allotment
With retail subscription at 401.21×, applications in that category exceeded the shares available to it by a factor of about 401.21. When a retail book is oversubscribed, the registrar does not allot proportionately — allotment runs as a computerised lottery among all valid applications, with each successful application receiving at least one lot of 600 shares — ₹1,24,800 of stock at the upper band. The multiple above is the data point that determines how thinly that draw is spread; it describes the final book, not the outcome of any single application.
Frequently asked questions
- When does the Avience Biomedicals IPO open and close?
- The Avience Biomedicals IPO opens on 18 Jun 2026 and closes on 22 Jun 2026.
- How many times was the Avience Biomedicals IPO subscribed?
- The Avience Biomedicals IPO was subscribed 385.24 times in total across all investor categories.
- What is the reservation split in the Avience Biomedicals IPO?
- Of the total shares offered, retail investors get 35.08%, QIBs 19.95% (plus 29.88% anchor), non-institutional investors 15.09%.